Robbert van de Griendt

Head of Investor Relations & Impact at BioGeneration Ventures

At BGV, Robbert is responsible for Fundraising and Investor Relations. He also leads Forbion’s ESG and impact investing efforts. Before joining Forbion Capital Partners, Robbert founded Accretion Capital Partners, advising asset managers structuring their products, raising funds for alternative asset classes, including Private Equity and Venture Capital, from Canadian and European institutions, family offices and accredited investors. Before launching his own firm, Robbert worked as partner at Virage Capital, a Canadian based consultancy providing services relating to the financing and formation of funds, companies and other investment vehicles. Prior to that, Robbert was partner at Neotech Capital, a venture capital firm specializing in incubation, helping start-ups thru early stages of investments. Of Dutch origin, Robbert has over 20 year of experience living and working across multiple industries in Asia, Europe and North-America. He holds a degree in Business Economics from the Erasmus University Rotterdam, The Netherlands.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


BioGeneration Ventures

BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €100 million of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.


Industries

Employees

11-50

Links